Free Content from Industry Partners


Transforming Drug Development with Big Data Analytics

Pharma has been relying on large clinical databases for years, and as an early adopter of powerful new tools such as artificial intelligence (AI) and complex analytics, the industry is now reaping rewards. Actionable results are being seen across the drug lifecycle including predictive modelling, trial design, personalised medicine and disease pattern analysis. What’s next? This report provides an overview of how big data analytics in pharma is evolving, and shares valuable insights from industry experts.

Download your copy of Transforming Drug Development with Big Data Analytics now

Success in Managed Markets: Payer Insights

US expenditure (per capita) on prescription drugs is at an all time high and showing no signs of reversing – so, it’s understandable that payers are totally focused on value. But when ‘value’ means different things to payers and manufacturers sitting on opposite sides of the negotiating table, how can agreement ever be reached? This free FirstWord Perspectives report, presented by Prognos, discusses the various types of value-based contract emerging and offers payer insights into the challenges involved.

Download your copy of Success in Managed Markets: Payer Insights now

Centralizing Medical Content to Achieve a Single Source of Truth

Medical affairs plays a strategic role as "the voice of life sciences organizations" when communicating accurate clinical data to healthcare professionals. This whitepaper explores the utility of scientific content and how a medical content management solution speeds the creation, approval, and delivery of medical content.

Download your copy of Centralizing Medical Content to Achieve a Single Source of Truth now

AGILE IRT: Improving Quality and Efficiency..

Historically, IRT study build processes followed a sequential, waterfall approach that introduced extra costs, time and—most importantly—errors that can affect the ability to launch the study on time or run the study as efficiently as possible. While incremental improvements seen so far in the industry are both welcome and meaningful, it is necessary for a broad change across the industry to fully embrace an agile approach to IRT and the benefits that will ultimately accrue to the sites running studies and their patients. Download our white paper and learn how to improve quality and efficiency in the study build process.

Download your copy of AGILE IRT: Improving Quality and Efficiency.. now

Embracing Digital Disruption in Pharma for Commercial Success

Tech giants and medical startups are upending healthcare business models faster than ever. Pharma needs to stop fearing digital disruption and start harnessing it for commercial success. Find out how innovative technologies can add value to everything from customer experience to physician engagement to clinical trials. Plus, learn how embracing digital solutions can transform Pharma, how to choose a chief digital officer (CDO) to lead the transition, and how to forge successful partnerships with tech companies.

Download your copy of Embracing Digital Disruption in Pharma for Commercial Success now

Biosimilars: Market Shaping Events, Issues and Trends

Get an up to date snapshot of the fast-changing Biosimilars landscape. Packed with vital insights for manufacturers, this must-read report reveals the top factors impacting Biosimilar adoption, the biggest challenges facing manufacturers, and the five things your company must do to achieve long-term success in the US and European pharmaceutical markets. You’ll also learn who the key players are, get a summary of important regulatory changes, and hear regulators’ latest thinking about critical issues.

Download your copy of Biosimilars: Market Shaping Events, Issues and Trends now

Pharma evolution and sales outsourcing as a change partner

The pharma industry is exploring new sales & marketing models to meet modern, multifaceted challenges. Historically, CSOs have provided a flexible, cost-effective means for pharma to adjust. However, given the current state of flux, just how relevant can CSOs be in helping pharma manage such major change? Ashfield, assisted by Dr Beth Rogers, has investigated this issue with 16 senior sales & buying professionals from pharma companies across Europe. Dr Beth Rogers is the author of Rethinking Sales Management & several papers on the outsourcing of sales functions.

Download your copy of Pharma evolution and sales outsourcing as a change partner now

The Future of MSL-KOL Engagement

The role of medical science liaison (MSL) has never been more important, or more challenging. Staying up to date with new scientific research and medical developments is daunting enough, but MSLs must also distil that data into relevant insights for information-hungry, outcomes driven KOLs. All while complying with increasingly stringent regulations. This free report lays out the biggest challenges MSLs are facing, and reveals the skills they must have to successfully engage KOLs in the coming years.

Download your copy of The Future of MSL-KOL Engagement now

Sales outsourcing as a change partner in the pharma industry

The pharma industry is exploring new sales and marketing models to meet modern, multifaceted challenges. Historically, CSOs have provided a flexible, cost-effective means for pharma to adjust. However, given the current state of flux, just how relevant can CSOs be in helping pharma manage such major change? Ashfield, assisted by Dr Beth Rogers, has investigated this issue with 16 senior sales and buying professionals from pharma companies across Europe. Dr Beth Rogers is the author of Rethinking Sales Management and several papers on the outsourcing of sales functions. Download our infographic on pharma evolution and sales outsourcing as a change partner.

Download your copy of Sales outsourcing as a change partner in the pharma industry now

About the Industry Partner Showcase

FirstWord Pharma's Industry Partner Showcase features content published by our industry partners that may be of interest to FirstWord readers. This content is provided free of charge by First Word sponsors.

Are you an Industry Partner? Contact us to have your own content showcased.